Table 3.
Excess relative rate per sievert for solid cancer types and COPD among a pooled cohort of workers from five United States nuclear facilities, follow-up through 2016a
| Solid cancer type | Deaths | ERR/Sv (95% CI) |
|---|---|---|
| Solid cancer (all) | 12 069 | 0.19 (−0.10, 0.52) |
| Solid cancer excluding lung | 8 198 | −0.01 (−0.34, 0.36) |
| Solid cancer excluding lung, liver and bone | 7 828 | 0.07 (−0.27, 0.47) |
| Non-smoking-related solid cancer | 3 819 | 0.11 (−0.37, 0.67) |
| Mouth and pharynx | 193 | NC |
| Oesophagus | 348 | 0.04 (−1.33, 2.21) |
| Stomach | 333 | 0.51 (−0.86, 2.90) |
| Colon | 1 141 | 0.08 (−0.81, 1.32) |
| Rectum | 224 | −1.03 (−1.99, 1.40) |
| Liver | 348 | −1.57 (−2.18, −0.23) |
| Pancreas | 784 | −0.29 (−1.09, 0.98) |
| Larynx | 84 | 2.35 (−0.79, 11.5) |
| Lung | 3 871 | 0.65 (0.09, 1.30) |
| Mesothelioma and pleural | 178 | 2.54 (−0.25, 7.10) |
| Skin (all) | 333 | 0.99 (−0.56, 3.43) |
| Skin excluding melanoma | 78 | 0.51 (−1.76, 5.19) |
| Skin (melanoma) | 255 | 1.24 (−0.67, 4.47) |
| Female breast | 385 | −1.16 (−3.26, 5.44) |
| Uterus | 30 | NC |
| Ovary | 128 | 5.74 (−5.65, 37.3) |
| Prostate | 1 324 | −0.19 (−0.75, 0.57) |
| Bladder | 405 | 0.04 (−0.96, 1.87) |
| Kidney | 371 | 0.93 (−0.98, 3.99) |
| Brain and CNS | 388 | −0.92 (−1.64, 0.64) |
| Thyroid | 30 | 0.77 (−2.82, 13.9) |
| Bone | 22 | −8.31 (−13.5, 9.93) |
| COPD | 2 527 | −0.04 (−0.61, 0.67) |
ERR/Sv, excess relative rate per sievert; NC, non-convergence; CNS, central nervous system; COPD, chronic obstructive pulmonary disease.
a
Matched on age, sex, date of birth, facility, duration of employment, neutron monitoring, and job type.